pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
402
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
DS-1103
Human Epidermal Growth Factor Receptor 2 Low Breast Cance…
Integral Molecular Inc
Phase 1
DS-2243
Solid Tumor
Daiichi Sankyo Co Ltd
Phase 1
DS-5361
Head And Neck Squamous Cell Carcinoma (HNSC)
Daiichi Sankyo Co Ltd
Phase 1
← prev
page 5 of 14
next →
131
Pain
89
Neurology
1
DS-9051
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Daiichi Sankyo Co Ltd
Phase 1
DVX-201
Myelodysplastic Syndrome (Preleukemia)
$COEP
Coeptis Therapeutics Holdings, Inc.
Phase 1
Deltacel
Non-Small Cell Lung Cancer
Immunocell Therapeutics Inc
Phase 1
Diakine-DK210 (EGFR)
Bladder Cancer
Deka Biosciences Inc
Phase 1
E-7766
Solid Tumor
Eisai Co Ltd
Phase 1
EBC-129
Pancreatic Ductal Adenocarcinoma
Agency for Science, Technology and Research
Phase 1
ELVN-001
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
$ELVN
Enliven Therapeutics, Inc.
Phase 1
ERAS-4001
Solid Tumor
$ERAS
Erasca, Inc.
Phase 1
ERSM-5404
Colorectal Cancer
Hibercell Inc
Phase 1
EVOLVE-104
Anal Cancer
EvolveImmune Therapeutics Inc
Phase 1
FID-022
Solid Tumor
Fulgent Pharma LLC
Phase 1
FORX-428
Metastatic Breast Cancer
FoRx Therapeutics AG
Phase 1
FPI-2068
Metastatic Colorectal Cancer
Fusion Pharmaceuticals Inc
Phase 1
FS-120
Advanced Malignancy
invoX Pharma Ltd
Phase 1
FT-522
B-Cell Non-Hodgkin Lymphoma
$FATE
FATE THERAPEUTICS INC
Phase 1
FT-576
Refractory Multiple Myeloma
$FATE
FATE THERAPEUTICS INC
Phase 1
FT-819
Idiopathic Inflammatory Myopathy (IIM)
$FATE
FATE THERAPEUTICS INC
Phase 1
FT-825
Colorectal Cancer
$FATE
FATE THERAPEUTICS INC
Phase 1
FT-836
Breast Cancer
$FATE
FATE THERAPEUTICS INC
Phase 1
G-207
Anaplastic Astrocytoma
Treovir LLC
Phase 1
GIGA-564
Solid Tumor
GigaGen Inc
Phase 1
GRN-300
Triple-Negative Breast Cancer (TNBC)
Greenfire Bio LLC
Phase 1
GS-0321
Solid Tumor
$GILD
GILEAD SCIENCES, INC.
Phase 1
GTB-3650
Myelodysplastic Syndrome (Preleukemia)
$GTBP
GT Biopharma, Inc.
Phase 1
GTB-5550
Epithelial Ovarian Cancer
$GTBP
GT Biopharma, Inc.
Phase 1
Gallium Maltolate
Recurrent Glioblastoma Multiforme (GBM)
$KMCM
Titan Holdings Corp.
Phase 1
Gene Therapy to Target CD22 for Oncology
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…
National Cancer Institute US
